Ampligen FDA Approval Status
FDA Approved: No
Brand name: Ampligen
Generic name: rintatolimod
Company: Hemispherx Biopharma, Inc.
Treatment for: Chronic Fatigue Syndrome
Ampligen (rintatolimod) is an experimental nucleic acid therapeutic in development for the treatment of a variety of chronic diseases and viral disorders.
Development timeline for Ampligen
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.